Physician profile
John Liu
NPI 1235161449
$14,180.49
in general payments reported to CMS, 2019-2025
10 companies · $3,733 in 2025
The $3,733 reported for 2025 was more than what 77% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $12.71 · 2022: $215 · 2023: $219 · 2024: $10K · 2025: $3,733.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Food and Beverage: $1,077 · Honoraria: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,875.00 |
| Food and Beverage | $1,077.43 |
| Honoraria | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novapproach Spine, LLC | $11,875.00 | 2024-2025 | Onelif |
| Gs Solutions, INC. | $1,000.00 | 2025 | |
| Medtronic, INC. | $847.69 | 2022-2025 | Mazor X System, Unid_pass, Medtronic Reusable Instruments |
| Globus Medical, INC. | $154.25 | 2025 | Excelsius Gps |
| Viseon, INC. | $131.69 | 2022 | |
| Alphatec Spine, INC | $57.40 | 2022 | |
| Abbvie INC. | $48.15 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $38.29 | 2024 | Farxiga |
| Abbott Laboratories | $15.31 | 2025 | Eterna |
| Siemens Medical Solutions USA, INC. | $12.71 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$193,441.03 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.